Cargando…
Can we conclude a potential therapeutic action for Parkinson’s disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?
Autor principal: | Segura-Aguilar, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030129/ https://www.ncbi.nlm.nih.gov/pubmed/29970885 http://dx.doi.org/10.1038/s41419-018-0798-0 |
Ejemplares similares
-
Crying wolf: concluding that wolves were not restored
por: Mech, L. David
Publicado: (2008) -
On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017) -
Life on Mars, can we detect it?
por: Stoker, Carol R.
Publicado: (2023) -
Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
por: McBride, Angela, et al.
Publicado: (2021) -
ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)